NVS

Novartis AG (NVS)

Last Price$109.41.9%
Market Cap$217.3B
LTM Gross margin
74.7%
5Y avg
70.8%
Drug Manufacturers - General industry median
69.6%
Stock quality & Intrinsic value
7/10
0.2% undervalued

Novartis AG Gross margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
NVS
Healthcare
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Gross margin
72.7%
72.0%
71.7%
73.1%
73.0%
71.9%
68.0%
67.4%
66.7%
67.7%
65.5%
64.6%
65.7%
65.4%
70.4%
69.7%
70.0%
70.1%
73.3%
75.2%
NVS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for NVS and see if it's the right time to invest.
Dive in

Novartis AG (NVS) Gross margin comparison analysis

Crunching data... Almost there!

NVS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Novartis AG's Gross margin?

As of today, Microsoft Corp's last 12-month Gross margin is 74.7%, based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Gross margin for Novartis AG have been 71.2% over the past three years, and 74.3% over the past five years.

2) Is Novartis AG's Gross margin Good?

As of today, Novartis AG's Gross margin is 74.7%, which is higher than industry median of 69.6%. It indicates that Novartis AG's Gross margin is Good.

3) How does Novartis AG's Gross margin compare to its peers?

As of today, Novartis AG's Gross margin is 74.7%, which is higher than peer median of 69.6%. The list of peers includes LLY, AZN, MRK, ABBV, SNY, JNJ, BMY, PFE, AMGN, GILD.